Disruptive technologies are typically just that because they are new, innovative, and have the potential to upend the norms in their respective fields. With this being said, it isn’t uncommon for companies involved with them to simultaneously boast high potential while remaining undervalued. The following are a few examples of this, with companies developing technologies involving AI, robotics, and more.
Undervalued Disruptive Tech Stocks
*Note: all figures are provided in USD, were accurate at the time of writing, and are subject to change. Rankings are in no particular order.*
1. Artificial Intelligence (AI) – Palantir Technologies Inc.
Palantir Technologies Inc. is a leading player in the field of big data analytics and artificial intelligence (AI). Founded in 2003, Palantir offers sophisticated data integration and analysis solutions primarily through two main platforms: Palantir Gotham and Palantir Foundry. Gotham is used predominantly by government agencies for counter-terrorism and military purposes, while Foundry serves commercial clients across various industries, including healthcare, finance, and manufacturing.
Why PLTR is Undervalued: Palantir’s stock has been volatile due to investor sentiment and skepticism about its business model, particularly its reliance on government contracts. Additionally, its high valuation ratios have led some to view the stock as overvalued. The company’s recent efforts to expand its commercial customer base have yet to fully reflect in its financial performance, causing some investor caution.
Growth Potential of PLTR: Palantir has significant growth potential due to several factors. The expansion of its commercial business, particularly through the Palantir Foundry platform, is helping organizations integrate and analyze large volumes of data, with substantial growth potential in industries like healthcare, finance, and manufacturing. This is important as the demand for advanced analytics and AI solutions is expected to rise, and Palantir’s capabilities position it well to capitalize on this trend.
Additionally, the company’s strong government contracts provide a stable revenue base while it pursues growth in the commercial sector. Strategic partnerships and collaborations also enhance Palantir’s product offerings and market reach.
Overall, Palantir Technologies Inc. presents a compelling investment opportunity due to its innovative technology, strategic expansion efforts, and growing market demand for data analytics and AI solutions. While currently undervalued due to market volatility and investor skepticism, its potential for substantial growth in the near term makes it an attractive stock to consider for those who believe in the future of AI.
2. Robotics – Teradyne, Inc.
Teradyne, Inc. provides automation equipment for testing semiconductors, electronics, and network products. The company also has a significant presence in the robotics market through its collaborative robots (cobots), which are gaining traction in industrial automation.
Why TER is Undervalued: Teradyne’s stock may be undervalued due to broader market fluctuations affecting the tech sector and concerns over semiconductor supply chain disruptions – which was something on full display during the height of COVID. These considerations have resulted in cautious investor sentiment despite the company’s strong fundamentals and diversified portfolio.
Growth Potential of TER: Importantly, Teradyne appears well positioned for high growth for several reasons. These include,
- the increasing automation in manufacturing and logistics drives demand for their advanced testing and robotics solutions
- the collaborative robots market is expected to grow significantly, and Teradyne’s innovative products are well-suited to capitalize on this trend
- the company is expanding into new industrial applications and markets, further broadening its growth opportunities.
When considering this growth potential alongside its already devalued stock, Teradyne, Inc. clearly offers a strong investment opportunity – especially given that it maintains a leading position in semiconductor testing and robotics.
3. Additive Manufacturing – Desktop Metal, Inc.
Desktop Metal, Inc. specializes in providing end-to-end additive manufacturing solutions (commonly referred to as ‘3D Printing’). Notably, it boasts innovative technology that is revolutionizing manufacturing by enabling faster production times and the use of a variety of materials. This has allowed for Desktop Metal to establish a strong position within the additive manufacturing market.
Why DM is Undervalued: Desktop Metal’s stock has been impacted by market skepticism towards SPAC mergers and the early-stage nature of widespread 3D printing adoption. This has led to an undervaluation despite the company’s strong technological innovations and expanding customer base.
Growth Potential of DM: Over the past few years, 3D printing has benefited more than most technologies due to various game-changing advancements in capabilities. These advancements allow for quicker, more complex end products to be made from a broader range of materials. Of even greater important is the technologies ability to provide cost savings through improved production efficiency.
This has naturally resulted in increased adoption of 3D printing across industries such as automotive, aerospace, and healthcare. All of these are expected to continue driving demand for solutions from companies like Desktop Metal.
At the end of the day, Desktop Metal, Inc. offers a promising investment opportunity due to its cutting-edge technology and expanding market presence. Currently, it could be considered undervalued due to operating within a nascent industry that is seeing many of its participants still undergoing initial price discovery. The technology’s potential alone, however, makes DM an intriguing stock play.
4. Energy Production – Enphase Energy, Inc.
Enphase Energy, Inc., is a provider of solar microinverters, battery storage, and energy management technology. Its solutions are key to the adoption of renewable energy systems, making solar energy more efficient and reliable for both residential and commercial use.
Why ENPH is Undervalued: Investor sentiment surrounding Enphase Energy has been somewhat muted, not necessarily due to its performance but lingering supply chain issues plaguing the solar industry and overall market corrections. With this being the case, Enphase Energy could be undervalued, as it continues to boast strong fundamentals while each of the aforementioned points is slowly resolving itself.
Growth Potential of ENPH: Enphase Energy is poised for significant growth for obvious but significant reasons. The global demand for renewable energy solutions is increasing showing no signs of slowing down. Of note is that Enphase’s advanced microinverter technology is critical in this transition.
Furthermore, the expansion of its energy storage and management solutions further strengthens its market position. At the same time, the increasing adoption of solar power in residential and commercial sectors provides substantial growth opportunities.
When considering Enphase Energy, Inc., it is clear that the company represents a compelling investment opportunity. With its leading-edge technology, expanding market reach, and resolving macro-factors, it appears well-primed to rebound from its current undervalued status.
5. Biotechnology – CRISPR Therapeutics AG
CRISPR Therapeutics AG is a company at the forefront of gene-editing technology. It currently maintains a focus on developing transformative gene-based medicines for serious diseases by leveraging technologies like CRISPR/Cas9. By doing so, it hopes to create potentially curative therapies for a range of genetic disorders, positioning itself as a leader in the biotechnology sector.
Why CRSP is Undervalued: CRISPR Therapeutics has faced volatility due to regulatory uncertainties and the early-stage nature of gene-editing technology. This has led to a cautious investor base despite the company’s pioneering research and significant potential for breakthroughs in genetic medicine.
Growth Potential of CRSP: CRISPR Therapeutics is poised for high growth and is driven by several key factors. The company’s pioneering work in CRISPR/Cas9 gene-editing technology offers the potential to cure or treat previously incurable genetic disorders. With an expanding pipeline of clinical trials and therapeutic applications, CRISPR Therapeutics is set to make substantial advancements in the biotechnology field. Additionally, as regulatory frameworks for gene editing evolve, the company’s market potential is expected to increase, and due to the technology’s staggering potential to do good, regulatory action should be supportive.
6. Augmented Reality/Virtual Reality (AR/VR) – Immersion Corporation
Immersion Corporation develops cutting-edge haptic feedback technology, which enhances user experiences across various devices by simulating touch sensations. Its innovations have widespread applications in gaming, automotive, mobile devices, and the emerging AR/VR sectors.
Why IMMR is Undervalued: Early difficulty in monetizing its haptic technology patents and market skepticism about the pace of AR/VR adoption has resulted in many companies within the sector being undervalued—Immersion Corporation included.
Growth Potential of IMMR: While early monetization may be difficult, it is important to recognize the sheer amount of industries that will be required to integrate the solutions on offer by Immersion Corporation in time. A few examples of these industries include,
- gaming
- educational and training devices
- automotive
- mobile devices
- smart home devices
In each of these examples, haptic feedback is increasingly integrated alongside AR/VR interfaces. Furthermore, the company already boasts strategic partnerships and licensing agreements that should further boost its market reach and revenue potential. Alongside its current undervalued status, this makes investing in Immersion Corporation worthy of consideration.
7. Aerospace – Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings, Inc. is a pioneer in the commercial spaceflight industry and is known for developing spacecraft meant to establish the space tourism and research industries. In time, the company aims to make space accessible to non-professional astronauts and researchers, offering unique experiences and advancing space exploration.
Why SPCE is Undervalued: Virgin Galactic’s stock has been affected by delays in commercial spaceflight operations and overall market sentiment. These delays, coupled with high operational costs and skepticism about the viability of the space tourism market, have led to an undervaluation of the stock despite the company’s pioneering position in the industry.
Growth Potential of SPCE: While SpaceX may be dominating the space-exploration conversation, there is certainly room for more than one innovative company in the aerospace sector. To that end, Virgin Galactic has clear and significant growth potential driven.
The company’s first-mover advantage in the commercial space tourism market positions it well to capitalize on growing interest and demand for space travel experiences. Additionally, the potential expansion into space research and scientific missions can diversify revenue streams and enhance growth opportunities. As the company overcomes operational hurdles and begins regular commercial flights, investor confidence is likely to increase, driving stock performance.
Due to the enormity of the task at hand, companies that boast initiatives like those of Virgin Galactic will always be greeted with a hearty helping of skepticism. If it can successfully overcome early operational delays and establish a firm footing in offering space tourism and research opportunities, this skepticism can easily be replaced by amazing growth potential, making it another ambitious company worth investment consideration.
8. Nanotechnology – Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global company that provides innovative solutions for a range of applications, including,
- life sciences
- pharmaceuticals
- biotechnology
- medical diagnostics
Its ability to serve such a broad range of sectors is partially due to its position at the forefront of nanotechnology development, which aids in the advancement of solutions that drive scientific discovery and improve healthcare outcomes.
Why TMO is Undervalued: In recent months, the entire healthcare and scientific research sectors have been suppressed by broad economic concerns and lingering high interest rates. As Thermo Fisher Scientific is closely linked to these sectors, it is unsurprising that its stock is now viewed as being undervalued – despite strong fundamentals and significant investments in nanotechnology.
Growth Potential of TMO: Thermo Fisher Scientific is poised for high growth driven by the company’s leadership in developing and manufacturing nanotechnology-based solutions, which position it well for expansion in life sciences and healthcare.
Its broad applications in pharmaceuticals, biotechnology, and medical diagnostics create multiple growth opportunities. Additionally, strategic acquisitions and partnerships enhance its nanotechnology capabilities and market reach, further driving growth potential.
9. Transportation – Nio Inc.
Nio Inc. is a Chinese electric vehicle (EV) manufacturer that focuses on premium EVs and innovative battery technologies. It is known for its stylish designs, high-performance vehicles, and advanced battery swap technology, allowing for Nio to become a major player in the rapidly growing EV market.
Why NIO is Undervalued: Nio’s stock has been impacted by market concerns over Chinese regulatory issues and global semiconductor shortages. Despite these concerns, the company has maintained a strong company brand while managing to grow its market presence on the back of continued technological innovation.
Growth Potential of NIO: This company is expanding its product lineup and continually innovating in battery technology – including its battery-as-a-service (BaaS) model, which enhances customer convenience and loyalty.
Nio is also growing its presence in international markets, which should continue to drive revenue growth. Additionally, the increasing global consumer adoption of electric vehicles positions Nio well to capitalize on this trend as governments continue to establish regulations that will force their adoption over the coming decade.
Overall, Nio Inc. offers a promising investment opportunity with its strong brand, innovative technology, and expanding market reach. Currently, it appears to be undervalued due to unanswered regulatory and supply chain questions. Still, the company’s potential for substantial growth in the near term makes it an attractive stock to consider.
10. Agriculture – Corteva, Inc.
Corteva, Inc. is an agricultural company that provides seed and crop protection solutions – something that is critical not just in North America but on a global scale. Notably, the company focuses on delivering innovative and sustainable products to enhance crop productivity and support farmers globally. To date, it has shown a strong commitment to research and development, as it aims to drive agricultural innovation and sustainability.
Why CTVA is Undervalued: Corteva might be undervalued due to market concerns over agricultural commodity prices and supply chain issues which are currently affecting many sectors. This has resulted in cautious investor sentiment despite the company’s strong fundamentals and innovative product offerings.
Growth Potential of CTVA: As it is at the forefront of seed and crop protection technologies, which are critical for increasing agricultural efficiency and sustainability, Corteva has a clear potential for growth. With global demand for sustainable farming practices growing, it continues to position itself well to benefit from the trend.
Additionally, the company has a robust research and development pipeline, ensuring a steady stream of new products to meet evolving market needs, making it another interesting stock to consider when looking to buy low and sell high.
Final Thoughts
These ten stocks, each leveraging unique disruptive technologies, are prime examples of companies that appear to be lopsided when comparing current valuations to growth potential. Interestingly, there is a common trend among each that has seen their respective valuations become suppressed due to macro events out of their control – largely supply chain issues and a high-interest environment that has resulted in investors fleeing to assets traditionally viewed as more stable (i.e., Dividend Kings). Thankfully for each, these factors appear to be abating, which should allow for many of these companies to see a sharp rebound in investor interest. Provided each continues to innovate in their respective field, they should be able to capitalize when the time comes.
For those considering investing in any of these companies, make sure to visit our look at the top online brokers that can make this possible for your region.